240 related articles for article (PubMed ID: 15242577)
1. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
Bockhorn M; Frilling A; Rewerk S; Liedke M; Dirsch O; Schmid KW; Broelsch CE
Thyroid; 2004 Jun; 14(6):468-70. PubMed ID: 15242577
[TBL] [Abstract][Full Text] [Related]
2. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
Papapetrou PD; Polymeris A
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
[TBL] [Abstract][Full Text] [Related]
3. Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma.
Alapat DV; Ain KB; Sloan DA; Monaghan KG; Karabakhtsian RG
Endocrine; 2011 Apr; 39(2):148-52. PubMed ID: 21243446
[TBL] [Abstract][Full Text] [Related]
4. Serum calcitonin-negative medullary thyroid carcinoma: role of CgA and CEA as complementary markers.
Giovanella L; Crippa S; Cariani L
Int J Biol Markers; 2008; 23(2):129-31. PubMed ID: 18629788
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
6. Paraganglioma-like medullary thyroid carcinoma: a rare entity.
Bockhorn M; Sheu SY; Frilling A; Molmenti E; Schmid KW; Broelsch CE
Thyroid; 2005 Dec; 15(12):1363-7. PubMed ID: 16405409
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
[TBL] [Abstract][Full Text] [Related]
8. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
[TBL] [Abstract][Full Text] [Related]
9. Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.
Hajje G; Borget I; Leboulleux S; Chougnet C; Al Ghuzlan A; Mirghani H; Caramella C; Hartl D; Schlumberger M; Baudin E
Eur J Endocrinol; 2013 Feb; 168(2):113-8. PubMed ID: 23093698
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin A: an additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas?
Franke WG; Pinkert J; Runge R; Bredow J; Wunderlich G; Koch R
Anticancer Res; 2000; 20(6D):5257-60. PubMed ID: 11326706
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of a hereditary medullary thyroid carcinoma case with normal preoperative serum calcitonin levels.
Zhang G; Jiang Y; Zhang S; Zhao L; Fan J; Zhang Z; Ma J; Chen R; Xu Y
Pathol Res Pract; 2019 Oct; 215(10):152529. PubMed ID: 31409511
[TBL] [Abstract][Full Text] [Related]
12.
Souteiro P; Gouveia P; Ferreira G; Belo S; Costa C; Carvalho D; Duarte H; Sampaio IL
Endocrine; 2019 May; 64(2):322-329. PubMed ID: 30684230
[TBL] [Abstract][Full Text] [Related]
13. Medullary thyroid carcinoma.
Pacini F; Castagna MG; Cipri C; Schlumberger M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin-like polypeptides without apparent biological activity in a patient with recurrent medullary thyroid carcinoma.
Nakajima K; Jinkawa I; Hirota T; Ikeda T; Tugawa M; Minami Y; Hanada M
Intern Med; 1995 Sep; 34(9):896-900. PubMed ID: 8580565
[TBL] [Abstract][Full Text] [Related]
15. [The routine immunohistochemical diagnosis and surgical treatment of medullary carcinoma of the thyroid].
Gavrailov M; Petkov R; Mladenov B; Todorov G; Kŭtev N
Khirurgiia (Sofiia); 1995; 48(2):17-9. PubMed ID: 8531439
[TBL] [Abstract][Full Text] [Related]
16. Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma.
Ide A; Ashizawa K; Ishikawa N; Ishii R; Ando T; Abe Y; Sera N; Usa T; Tominaga T; Ejima E; Nakashima M; Ito K; Ito K; Eguchi K
Thyroid; 2001 Nov; 11(11):1055-61. PubMed ID: 11762716
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
[TBL] [Abstract][Full Text] [Related]
18. Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.
Pelizzo MR; Torresan F; Da Roit A; Merante Boschin I; Chondrogiannis S; Rampin L; Colletti PM; Vinjamury S; Perkins AJ; Rubello D
Rev Esp Med Nucl Imagen Mol; 2015; 34(6):378-82. PubMed ID: 26420439
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
Frank-Raue K; Machens A; Leidig-Bruckner G; Rondot S; Haag C; Schulze E; Lorenz A; Kreissl MC; Dralle H; Raue F; Schmid KW
Thyroid; 2013 Mar; 23(3):294-300. PubMed ID: 22946486
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers in the follow-up of medullary thyroid cancer.
de Groot JW; Kema IP; Breukelman H; van der Veer E; Wiggers T; Plukker JT; Wolffenbuttel BH; Links TP
Thyroid; 2006 Nov; 16(11):1163-70. PubMed ID: 17123344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]